1. Home
  2. IPSC vs IXHL Comparison

IPSC vs IXHL Comparison

Compare IPSC & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$0.92

Market Cap

58.3M

Sector

Health Care

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.41

Market Cap

49.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPSC
IXHL
Founded
2019
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.3M
49.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IPSC
IXHL
Price
$0.92
$0.41
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
1.5M
12.2M
Earning Date
11-13-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$113,337,000.00
$12,000.00
Revenue This Year
$1,590.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4122.69
N/A
52 Week Low
$0.34
$0.08
52 Week High
$1.19
$2.25

Technical Indicators

Market Signals
Indicator
IPSC
IXHL
Relative Strength Index (RSI) 61.52 52.15
Support Level $0.91 $0.35
Resistance Level $1.05 $0.47
Average True Range (ATR) 0.12 0.03
MACD 0.01 -0.00
Stochastic Oscillator 66.72 48.04

Price Performance

Historical Comparison
IPSC
IXHL

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: